A nurse is caring for a critically ill client who has a double-lumen peripherally inserted central catheter (PICC). Lumen 1 is infusing continuous norepinephrine, and Lumen 2 is infusing 0.9% sodium chloride at a keep-vein-open rate. The healthcare provider prescribes a continuous infusion of pantoprazole, an intermittent IV piggyback of vancomycin, and a STAT dose of IV push furosemide . The client's total urine output over the past 2 hours is . Which of the following nursing actions are appropriate? Select all that apply.
- Withhold the vancomycin dose and notify the healthcare provider of the recent urine output.Answer
- BAdminister the IV push furosemide through the injection port on the norepinephrine line.
- Flush the designated IV line with 0.9% sodium chloride before and after the furosemide administration.Answer
- Administer the dose of IV push furosemide over a period of at least 2 minutes.Answer
- EConnect the pantoprazole infusion to the Y-site of the continuous norepinephrine line since both medications are appropriate for central venous administration.
- FProgram the infusion pump to deliver the vancomycin dose over 30 minutes to rapidly achieve therapeutic trough levels.
Answer
The appropriate actions are withholding the vancomycin due to oliguria, flushing the IV line before and after furosemide administration, and pushing the furosemide over at least 2 minutes.
Safe administration of high-risk parenteral therapies requires analyzing multiple client factors simultaneously. Vancomycin is highly nephrotoxic; the client's severe oliguria () strongly indicates acute kidney injury, necessitating holding the drug and notifying the provider to prevent irreversible renal failure. Flushing the line before and after furosemide prevents precipitation, as furosemide is chemically incompatible with many medications. Furosemide must be administered no faster than to prevent permanent ototoxicity; therefore, a dose requires at least 2 minutes.
Step-by-Step Solution
Key Concept
Complex multi-medication parenteral therapy requires synthesis of pharmacokinetics (nephrotoxicity, ototoxicity), safe administration rates (preventing infusion reactions), and physical IV line dynamics (preventing pressor bolusing and chemical precipitation).